Trial · NCT01380743

Adverse events176

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 176

Type	Event	Organ system	Group	Affected	At risk
other	Dental caries	Gastrointestinal disorders	Cohort 1, Duvoglustat 50 mg + rhGAA	1	6
other	Dental caries	Gastrointestinal disorders	Cohort 2, Duvoglustat 100 mg + rhGAA	0	6
other	Dental caries	Gastrointestinal disorders	Cohort 3, Duvoglustat 250 mg + rhGAA	0	6
other	Dental caries	Gastrointestinal disorders	Cohort 4, Duvoglustat 600 mg + rhGAA	0	7
other	Oedema peripheral	General disorders	Cohort 1, Duvoglustat 50 mg + rhGAA	0	6
other	Oedema peripheral	General disorders	Cohort 2, Duvoglustat 100 mg + rhGAA	0	6
other	Oedema peripheral	General disorders	Cohort 3, Duvoglustat 250 mg + rhGAA	2	6
other	Oedema peripheral	General disorders	Cohort 4, Duvoglustat 600 mg + rhGAA	0	7
other	Post procedural haematoma	Injury, poisoning and procedural complications	Cohort 1, Duvoglustat 50 mg + rhGAA	0	6
other	Post procedural haematoma	Injury, poisoning and procedural complications	Cohort 2, Duvoglustat 100 mg + rhGAA	1	6
other	Post procedural haematoma	Injury, poisoning and procedural complications	Cohort 3, Duvoglustat 250 mg + rhGAA	1	6
other	Post procedural haematoma	Injury, poisoning and procedural complications	Cohort 4, Duvoglustat 600 mg + rhGAA	0	7
other	Procedural pain	Injury, poisoning and procedural complications	Cohort 1, Duvoglustat 50 mg + rhGAA	0	6
other	Procedural pain	Injury, poisoning and procedural complications	Cohort 2, Duvoglustat 100 mg + rhGAA	2	6
other	Procedural pain	Injury, poisoning and procedural complications	Cohort 3, Duvoglustat 250 mg + rhGAA	4	6
other	Procedural pain	Injury, poisoning and procedural complications	Cohort 4, Duvoglustat 600 mg + rhGAA	0	7
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Cohort 1, Duvoglustat 50 mg + rhGAA	2	6
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Cohort 2, Duvoglustat 100 mg + rhGAA	0	6
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Cohort 3, Duvoglustat 250 mg + rhGAA	0	6
other	Pain in extremity	Musculoskeletal and connective tissue disorders	Cohort 4, Duvoglustat 600 mg + rhGAA	1	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01380743/events

API reference For AI assistants

Adverse events176

Sources 3

Read this list from software.